Abstract
From the Northeastern Ohio Universities College of Medicine and Pharmacy, Rootstown and Summa Health System, Akron, OH. Reprints: Thomas M. File Jr, MD, 75 Arch St, Suite 506, Akron, OH 44304. E-mail: [email protected]. The author discloses that he has received recent research funding from Cerexa/Forest, Ortho-McNeil, Pfizer, Boehringer Ingelheim, Gilead, and Tibotec and is a consultant for Cerexa/Forest, Ortho-McNeil, Protez, Merck, Nabriva, and Pfizer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
